NEW YORK — UK reagent firm RevoluGen said on Monday that it has signed a global manufacturing deal for its Fire Monkey/Fire Flower high molecular weight DNA extraction and purification product with GE Healthcare Life Sciences.
The Fire Monkey/Fire Flower uses spin columns to extract high molecular weight DNA with an average length of 100 kb or more from animal and bacterial cells, followed by the removal of DNA fragments smaller than 10 kb.
Under the terms of the deal, GE Healthcare Life Sciences will non-exclusively manufacture the product for RevoluGen. Additional terms were not disclosed.
"With this manufacturing agreement we will be able to ensure a high-quality supply of our world-leading Fire Monkey/Fire Flower product from a source sufficiently flexible to be able to cope with any global scale up in demand," RevoluGen CEO Pieter Haitsma Mulier said in a statement.
In mid-2019, RevoluGen signed on Merck KGaA as a non-exclusive global distributor of the Fire Monkey/Fire Flower product.